FDA Drug Application (062662) for TAZICEF by HOSPIRA

Back to FDA Applications sponsored by HOSPIRA

Application Number062662
Product Number001
FormINJECTABLE;INJECTION
Dosage500MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameTAZICEF
Active IngredientCEFTAZIDIME

Active IngredientCount
List of drugs with Active Ingredient CEFTAZIDIME9


Back to FDA Applications sponsored by HOSPIRA